IMUX
IMMUNIC, INC.
NASDAQ · Healthcare · Biotechnology · US
$10.62
+2.61%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.94
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.80
- EPS estimate
- -$1.16
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -1.1%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $34
- PT range
- $22 – $45
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$1.16 | -$0.80 | Beat 31.03% | — |
| May 13, 2026 | -$0.71 | -$1.08 | Miss -52.11% | — |
| Nov 13, 2025 | -$0.18 | -$0.13 | Beat 27.78% | — |
| Aug 7, 2025 | -$0.18 | -$0.20 | Miss -11.11% | — |
| May 15, 2025 | -$0.25 | -$0.25 | In line | — |
| Mar 27, 2025 | -$0.22 | -$0.25 | Miss -13.64% | — |
| Nov 7, 2024 | -$0.22 | -$0.24 | Miss -9.09% | — |
| Feb 22, 2024 | -$0.51 | -$0.48 | Beat 5.88% | — |
| Nov 14, 2023 | -$0.55 | -$0.51 | Beat 7.27% | — |
| Aug 3, 2023 | -$0.52 | -$0.54 | Miss -3.85% | — |
| May 11, 2023 | -$0.54 | -$0.58 | Miss -7.41% | — |
| Feb 23, 2023 | -$0.82 | -$1.63 | Miss -98.78% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026